ZEB2 and glioma: Overexpression of ZEB2 is implicated in various malignant carcinomas, reflecting that ZEB2 promotes tumor metastasis, invasiveness and correlates with poor prognosis of human colorectal cancer, glioma, acute myeloid leukemia and small cell lung cancer [19,35–38].